High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
17.14B
+3.84%
8.247
+7.53%
17.19B
+4.5%
6.875
+94.77%
17.63B
+5.97%
4.298
-27.65%
Estimates Revision
The market is revising Downward the revenue expectations for The Allstate Corporation (ALL) for FY2025, with the revenue forecasts being adjusted by -0.56% over the past three months. During the same period, the stock price has changed by -0.94%.
Revenue Estimates for FY2025
Revise Downward
-0.56%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+33.53%
In Past 3 Month
Stock Price
Go Down
-0.94%
In Past 3 Month
17 Analyst Rating
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 241.50 USD with a low forecast of 201.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
3 Hold
1 Sell
Moderate Buy
Current: 206.370
Low
201.00
Averages
241.50
High
300.00
Current: 206.370
Low
201.00
Averages
241.50
High
300.00
Roth Capital
Harry Fong
Buy
maintain
$230 -> $240
2025-11-26
Reason
Roth Capital
Harry Fong
Price Target
$230 -> $240
2025-11-26
maintain
Buy
Reason
Roth Capital analyst Harry Fong raised the firm's price target on Allstate to $240 from $230 and keeps a Buy rating on the shares. The company's "significant earnings beat" was chiefly due to much better underlying results and favorable loss reserve development in personal auto injury and physical damage coverages, while its personal auto policies-in-force increased 1.3%, which was previously disclosed, the analyst tells investors in a research note.
HSBC
Vikram Gandhi
Hold -> Buy
upgrade
$267 -> $259
2025-11-17
Reason
HSBC
Vikram Gandhi
Price Target
$267 -> $259
2025-11-17
upgrade
Hold -> Buy
Reason
HSBC analyst Vikram Gandhi upgraded Progressive (PGR) to Buy from Hold with a price target of $259, down from $267. Progressive shares have underperformed closest peer Allstate (ALL) by about 26% and the S&P 500 by about 36% since mid-April, notes the analyst, who attributes this to a combination of headwinds faced by its personal auto business given slowing policy-in-force growth driven by intense competition, increasingly fading pricing momentum and falling interest rates. However, while the firm thinks the underperformance was "justified to some extent," it sees this presenting an opportunity as the firm notes that management emphasized on the Q3 call that it remains focused on growth, but not at the cost of profitability and the firm views regulatory moves to unlock excess capital and share buybacks being added to the capital returns mix as positives.
Keefe Bruyette
Outperform
maintain
$246 -> $250
2025-11-11
Reason
Keefe Bruyette
Price Target
$246 -> $250
2025-11-11
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Allstate to $250 from $246 and keeps an Outperform rating on the shares.
UBS
Buy
maintain
$250 -> $255
2025-11-10
Reason
UBS
Price Target
$250 -> $255
2025-11-10
maintain
Buy
Reason
UBS raised the firm's price target on Allstate to $255 from $250 and keeps a Buy rating on the shares.
Wells Fargo
Equal Weight
maintain
$202 -> $216
2025-11-07
Reason
Wells Fargo
Price Target
$202 -> $216
2025-11-07
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on Allstate to $216 from $202 and keeps an Equal Weight rating on the shares. The firm notes shares traded up on strong margin and bottom-line quarter and optimism on retention / growth improving, as they are broadly rate adequate across their auto book. Wells believes this was somewhat counterbalanced by the company not leaning into buyback.
BMO Capital
Michael Zaremski
Outperform
maintain
$235 -> $244
2025-11-07
Reason
BMO Capital
Michael Zaremski
Price Target
$235 -> $244
2025-11-07
maintain
Outperform
Reason
BMO Capital analyst Michael Zaremski raised the firm's price target on Allstate to $244 from $235 and keeps an Outperform rating on the shares after its Q3 results. The firm notes that while auto loss ratios will begin moving higher next year given rate increase are in the very low single digits, its estimates improve off a lower/better loss ratio starting point, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Allstate Corp (ALL.N) is 8.44, compared to its 5-year average forward P/E of 1.76. For a more detailed relative valuation and DCF analysis to assess Allstate Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
1.76
Current PE
8.44
Overvalued PE
42.85
Undervalued PE
-39.32
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
2.79
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.78
Undervalued EV/EBITDA
-2.19
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.71
Current PS
0.00
Overvalued PS
0.82
Undervalued PS
0.60
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased2087.5%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
ALL News & Events
Events Timeline
(ET)
2025-11-20
08:17:20
Allstate reports estimated catastrophe losses of $83 million for October
2025-11-05 (ET)
2025-11-05
17:56:38
Allstate announces Q3 adjusted EPS of $11.17, surpassing consensus estimate of $7.54
2025-11-05
14:25:59
Prominent Companies Set to Report After Market Hours
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/3ce58c35e0363038a1d20dabb7051b83f462ad54f5c3086021b93ecb80abfc71.jpg)
Preview
3.0
12-04NASDAQ.COMTop Growth Stocks to Consider Purchasing on December 4
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/90bcc518b8deccc76ec5ce546805a3527c4f0d98f4ec148e0195bbf5fee93c45.jpg)
Preview
3.0
12-02NASDAQ.COMTop Growth Stocks to Consider Purchasing on December 2
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/527e925552a36b8f3fd45c4906149300017760f830597c0e44d5cafade137b0c.jpg)
Preview
3.0
12-02NASDAQ.COMFour Promising Low-PEG Value Stocks Set to Excel in the Market
Sign Up For More News
People Also Watch
FAQ
What is Allstate Corp (ALL) stock price today?
What is Allstate Corp (ALL)'s business?
What is the price predicton of ALL Stock?
What is Allstate Corp (ALL)'s revenue for the last quarter?
What is Allstate Corp (ALL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Allstate Corp (ALL)'s fundamentals?
How many employees does Allstate Corp (ALL). have?